Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

Pressure BioSciences Announces Achievement of First Major Milestone in Development of Potential Breakthrough Processing Method for Higher Quality and Safer Food and Beverages
BiotechnologyCompany Update

Pressure BioSciences Announces Achievement of First Major Milestone in Development of Potential Breakthrough Processing Method for Higher Quality and Safer Food and Beverages

June 26, 2019 9:05 AM

Proprietary, Custom Built UST-Based Instrument Delivered to Collaborators at The Ohio State University; OSU Scientists to Study Pressure and Shear Effects on Pathogen Inactivation, Stability, and Quality SOUTH EASTON, MA / ACCESSWIRE / June 26, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences...

Read more
Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global Conference
BiotechnologyCompany Update

Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global Conference

June 24, 2019 11:00 AM

Clinical Manifestations of CVI Improved an Average of 46% Across All Five VenoValve Patients IRVINE, CA / ACCESSWIRE / June 24, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that on Sunday, June 23, 2019, Dr. Jorge Hernando Ulloa, the Primary Investigator for HJLI's first-in-human VenoValve study in Bogota, Colombia, reported new and updated...

Read more
Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock
BiotechnologyCompany Update

Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock

June 24, 2019 9:08 AM

FRAMINGHAM, MA / ACCESSWIRE / June 24, 2019 / Xenetic Biosciences, Inc. (NASDAQ: XBIO) ("Xenetic" or the "Company"), today announced it will effect a one-for-twelve reverse stock split of its issued and outstanding common stock. Pursuant to the Certificate of Change filed with the Secretary of State of the State of Nevada, the reverse stock split will be effective at 12:01 a.m., Eastern Time, on June 25, 2019. Xenetic expects that upon the...

Read more
Hemogenyx Pharmaceuticals PLC Announces Development of ApbHC
BiotechnologyCompany UpdateRegulatory

Hemogenyx Pharmaceuticals PLC Announces Development of ApbHC

June 24, 2019 2:00 AM

Development of ApbHC, a Novel Type of Humanized Mouse LONDON / ACCESSWIRE / June 24, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that its wholly owned subsidiary Immugenyx, LLC ("Immugenyx") has developed an Advanced peripheral blood Hematopoietic Chimera ("ApbHC"), a novel type of humanized mouse that presents several advantages over other mouse models. Immugenyx was established by the Company to develop and commercialise the...

Read more
Experion’s Brand, Kanabé Goods Co., Well Positioned to Take Advantage of New Health Canada Regulations
BiotechnologyCompany Update

Experion’s Brand, Kanabé Goods Co., Well Positioned to Take Advantage of New Health Canada Regulations

June 21, 2019 8:30 AM

VANCOUVER, BC / ACCESSWIRE / June 21, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF), formerly Viridium Pacific Group Ltd., is pleased to provide an update on the Company's brands positioned to take advantage of Health Canada's final regulations for Value-Add Products (VAP's) such as cannabis topicals, edibles and extracts as well as Health Canada's proposal to create a new category ''Cannabis Health...

Read more
Hancock Jaffe Hires Brian Roselauf as Director of Research and Development
BiotechnologyCompany Update

Hancock Jaffe Hires Brian Roselauf as Director of Research and Development

June 20, 2019 8:31 AM

IRVINE, CA / ACCESSWIRE / June 20, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announced that Brian Roselauf will be joining the company as its Director of Research and Development. Mr. Roselauf will join Hancock Jaffe on June 24, 2019, and will initially focus on design verification and validation activities to prepare for the filing of the...

Read more
Hancock Jaffe Primary Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Report at the Venous Summit at the C3 Global Conference
BiotechnologyCompany Update

Hancock Jaffe Primary Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Report at the Venous Summit at the C3 Global Conference

June 19, 2019 1:30 PM

VenoValve Presentation on June 23, 2019 in Orlando, Florida IRVINE, CA / ACCESSWIRE / June 19, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that Dr. Jorge Hernando Ulloa, HJLI's Primary Investigator for its first-in-human VenoValve study in Bogota, Colombia, will report on initial VenoValve data at the 2019 Venous Summit at the 15th annual...

Read more
Pressure BioSciences' Ultra High Pressure HUB Platform Highly Effective in Studies to Develop Improved Methods for Food Safety
BiotechnologyCompany Update

Pressure BioSciences' Ultra High Pressure HUB Platform Highly Effective in Studies to Develop Improved Methods for Food Safety

June 19, 2019 9:32 AM

HUB Platform Plays Critical Role in Innovative Research Studies Designed to Increase Understanding of and Develop Methods for the Prevention of Serious Food-Borne Diseases Caused by E. coli and Listeria SOUTH EASTON, MA / ACCESSWIRE / June 19, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology...

Read more
GreenStar Biosciences Announces Senior Management Addition
BiotechnologyCompany Update

GreenStar Biosciences Announces Senior Management Addition

June 19, 2019 8:30 AM

VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / GreenStar Biosciences Corp. ("GreenStar" or the "Company") (CSE: GSTR) is pleased to announce that, effective today, Mr. Rahim Rajwani has been appointed as Chief Executive Officer of the Company. Mr. Ralph Olson, the Company's current CEO, will be moving to the role of President of GreenStar. Subject to final board approval, Mr. Rajwani will also join the board of directors of the Company. Leighton...

Read more
Vitro Bio-Pharma 2nd Quarter Ended April 30th 2019 Financial Results of Operations
BiotechnologyCompany UpdateEarnings

Vitro Bio-Pharma 2nd Quarter Ended April 30th 2019 Financial Results of Operations

June 18, 2019 4:10 PM

GOLDEN, CO / ACCESSWIRE / June 18, 2019 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2019 financial results of operations. Vitro Diagnostics Inc. ("Vitro Biopharma") is pleased to announce a record 2nd quarter in Stem Cell Revenues. Vitro Biopharma recorded 2nd quarter revenues of $211,900 vs $125,103 an increase of 69% over the same comparative quarter last year. In addition, Stem Cell...

Read more
GreenStar Biosciences Provides Corporate Update
BiotechnologyCompany Update

GreenStar Biosciences Provides Corporate Update

June 18, 2019 9:00 AM

VANCOUVER, BC / ACCESSWIRE / June 18, 2019 / GreenStar Biosciences Corp. ("GreenStar" or the "Company") (CSE: GSTR) is pleased to provide the following corporate update with respect to the business and prospects of GreenStar Biosciences Corp. GreenStar's current primary business involves the leasing, branding and intellectual property of Cowlitz County Cannabis Cultivation Inc. ("Cowlitz"), a licensed cannabis producer and processor located in...

Read more
Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human Study
BiotechnologyCompany Update

Hancock Jaffe Successfully Completes VenoValve Implantation for First-in-Human Study

June 13, 2019 8:31 AM

Six Patients Now Part of First-in-Human Bogota Study IRVINE, CA / ACCESSWIRE / June 13, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, has successfully implanted the VenoValve in an additional patient. The procedure very went well and there are no early signs of adverse events. Six out of the ten patients that are to be a part of the initial phase of HJLI's...

Read more
Pressure BioSciences' PCT Platform Prominently Featured in Record Number of Presentations at Major International Science Conference
BiotechnologyCompany Update

Pressure BioSciences' PCT Platform Prominently Featured in Record Number of Presentations at Major International Science Conference

June 12, 2019 9:27 AM

Scientists from Leading Laboratories in Europe, Asia, Oceania, and North America Highlight the Critical Importance of PBI's Patented PCT System in Cancer and Other Priority Research Areas SOUTH EASTON, MA / ACCESSWIRE / June 12, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-base instruments, consumables, and platform technology solutions to the...

Read more
Hancock Jaffe Announces Pricing of Public Offering of Common Stock
BiotechnologyCompany Update

Hancock Jaffe Announces Pricing of Public Offering of Common Stock

June 12, 2019 9:00 AM

Company Fortifies Balance Sheet Ahead of Key Milestones IRVINE, CA / ACCESSWIRE / June 12, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of its public offering of 3,615,622 shares of its common stock at a price to the public of $1.07 per share, for expected total gross proceeds of approximately $3.9 million, before deducting...

Read more
Greenstar Announces Execution of Long Term Cannabis Flower Supply Agreement
BiotechnologyCompany Update

Greenstar Announces Execution of Long Term Cannabis Flower Supply Agreement

June 12, 2019 8:00 AM

VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / Greenstar Biosciences Corp. ("Greenstar" or the "Company") (CSE: GSTR) is pleased to announce that its tenant partner in Washington State, Cowlitz County Cannabis Cultivation, Inc. ("Cowlitz"), has signed a long-term supply agreement with Pat Dullanty, owner and operator of an 18 acre tier 3 outdoor grow facility located at 26425 S Rupp Rd, Cheney, Washington 99001. Pursuant to this new agreement,...

Read more
THC Farmaceuticals Receives Patent Protection in Republic of South Africa For Methods of Producing Antibody- Rich Cannabis and Honeysuckle Plants
BiotechnologyCompany UpdateProduct Announcements

THC Farmaceuticals Receives Patent Protection in Republic of South Africa For Methods of Producing Antibody- Rich Cannabis and Honeysuckle Plants

June 12, 2019 6:00 AM

THOUSAND OAKS, CA / ACCESSWIRE / June 12, 2019 / CBDual Biotechnology Corp., a subsidiary of THC Farmaceuticals, Inc (OTC PINK: CBDG) today announced that its parent company has been granted patent protection for the South African Patent Application No. 2017/01966 regarding the parent company's Methods of Producing Antibody- Rich Cannabis and Honeysuckle Plants. South African Republic's Patent Office has scheduled publication of this...

Read more
Dyadic to Ring the Nasdaq Closing Bell on June 17, 2019
BiotechnologyCompany Update

Dyadic to Ring the Nasdaq Closing Bell on June 17, 2019

June 11, 2019 8:50 AM

JUPITER, FL / ACCESSWIRE / June 11, 2019 / Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scale today announced that its President and Chief...

Read more
Experion Adds Veteran Financial and Business Magnate to Board of Directors with the Appointment of William (Bill) Kenneth Dickie
BiotechnologyCompany UpdateManagement Changes

Experion Adds Veteran Financial and Business Magnate to Board of Directors with the Appointment of William (Bill) Kenneth Dickie

June 11, 2019 8:30 AM

VANCOUVER, BC / ACCESSWIRE / June 11, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSX-V: EXP), formerly Viridium Pacific Group Ltd., is pleased to announce the appointment of a new member to its Board of Directors. Mr. William (Bill) Kenneth Dickie will join Mr. Jay Garnett, Chief Executive Officer of Experion Holdings Ltd, on the Board of Directors effective June 11, 2019. Mr. Dickie brings substantial financial oversight and...

Read more
Molecular Partners Announces Scientific Leadership Transition After Successful Transformation of Research Organization to Focus on Novel DARPin (R) Therapeutics in Oncology
BiotechnologyInvestor Relations

Molecular Partners Announces Scientific Leadership Transition After Successful Transformation of Research Organization to Focus on Novel DARPin (R) Therapeutics in Oncology

June 11, 2019 1:00 AM

Pamela A. Trail, Ph.D., to transition from Chief Scientific Officer to strategic consultant; Daniel Steiner, Ph.D., to assume leadership of research organization ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 11, 2019 / Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company that is developing a new class of drugs known as DARPin® therapies*, today announced that Pamela A. Trail, Ph.D., will depart from her role as Chief...

Read more
Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve Study
BiotechnologyCompany Update

Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve Study

June 7, 2019 8:31 AM

Reflux Significantly Reduced in Four out of Five Patients IRVINE, CA / ACCESSWIRE / June 7, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announced early positive results from its first-in-human VenoValve Study in Bogota, Colombia. Deep venous reflux has been significantly reduced in 4 out of the first 5 patients that have received VenoValves. Reflux...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?